Trump approval rating: U.S. President won rural voters by 40 points in the 2024 election, up from 31 points in the 2020 election and 25 poi...

In a challenging political landscape, President Trump faces an uphill battle with rural Americans, whose approval ratings are slipping. The...

President Donald Trump's pardon system has shifted dramatically. Influence now hinges on personal networks and narratives of victimhood, by...

A rift has emerged between the CIA and the nation's top spy office. The CIA is withholding contributions to key intelligence reports. This ...

America's inflation rate has reached a three-year peak. Higher energy costs are a major factor. This situation is expected to keep interest...

A fragile ceasefire in Lebanon has faltered. Israel's military campaign is expanding, forcing thousands of civilians from their homes. Evac...

A small group of nine anonymous crypto wallets now wield significant power over Polymarket's prediction markets. These wallets control outc...

After a landmark Supreme Court ruling, U.S. businesses are strategically striving to salvage billions in refunds from now-invalid tariffs. ...

A Trump administration plan aimed to ban Dominion voting machines. Officials considered declaring components national-security risks. This ...

Warren Buffett divided the investment universe into Inevitables, Highly Probables, and Impostors. The Inevitables are companies whose domin...

SpaceX's AI chatbot Grok faces significant challenges gaining traction within the U.S. government. Federal agencies show a strong preferenc...

Donald Trump is purging Republican politicians who have not shown him loyalty. This strategy energizes his core supporters. However, some R...

Wrapping up a two-day summit in Beijing, Trump has taken a step towards reducing tensions, but the gathering did not result in any major tr...

Warren Buffett once revealed a brutally simple test for separating great businesses from merely good ones: Could you put a lazy, not-too-sm...

President Trump's administration projects significant savings from deals with drug companies. These agreements aim to lower US prescription...

Wall Street's 'sell in May' advice might be a mistake this year. Despite historical trends, the S&P 500's strong rebound, fueled by easing ...

Blindly following the old Wall Street adage "sell in May and go away" may prove costly, as investors weigh whether to call time on a powerf...